Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study investigated the relationship of obesity, insulin resistance, inflammation and angiogenesis with cancer progression and survival in a colorectal cancer cohort. METHODS: Clinical and pathological data, along with anthropometric and follow-up data, were collected from 344 consecutive colorectal cancer patients. Serum samples at diagnosis were analysed by immunoassay for adiponectin, C-reactive protein (CRP), vascular endothelial growth factor-A (VEGF-A), angiopoietin-2 (Ang-2), insulin-like growth factor-1 (IGF-1), insulin and C-peptide. RESULTS: Serum Ang-2 and VEGF-A levels increased with tumour T stage (P=0.007 and P=0.025, respectively) and N stage (P=0.02 and P=0.03, respectively), and correlated with CRP levels (r=0.43, P<0.001 and r=0.23, P<0.001, respectively). Angiopoietin-2 correlated with C-peptide (r=0.14, P=0.007) and VEGF-A with IGF-1 in males (r=0.25, P=0.001). Kaplan-Meier analysis showed that patients with high serum levels of CRP and Ang-2 had significantly reduced survival (both P≤0.001). After adjusting for tumour stage and age, Ang-2 remained a significant predictor of survival. The CRP levels were inversely associated with survival in American Joint Committee on Cancer stage II patients (P=0.038), suggesting that CRP could be used to support treatment decisions in this subgroup. Serum markers and anthropometric measures of obesity correlated with each other, but not with survival. CONCLUSION: Our study supports the concept that obesity-related inflammation, rather than obesity itself, is associated with colorectal cancer progression and survival. The study confirms serum Ang-2 as a predictive marker for outcome of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Experimental and epidemiological studies support the concept that chronic inflammation has cancer-promoting properties (Mantovani et al, 2008; Porta et al, 2009).”
BackgroundAmerican Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“While total serum levels of adiponectin and IGF-1 were measured, our assay system was unable to distinguish high molecular weight multimers of adiponectin, which represent the most biologically active form (Kadowaki et al, 2006), and may have better predictive value.”
MethodInflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 1×
“It is now well established that obesity is characterised by chronic inflammation (Greenberg and Obin, 2006; Park et al, 2010), with associated increases of CRP, interleukin-6 (IL-6) and plasminogen activator inhibitor (Dandona et al, 2004).”
BackgroundPark, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 2×
“Recent in vivo data in dietary and genetically obese mouse models demonstrated obesityrelated liver inflammation and subsequent release of IL-6 and TNFa (Park et al, 2010).”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 3×
“…of obesity and metabolic syndrome as risk factors for colorectal cancer development, data are equivocal for their effects on colorectal cancer progression and outcome (Trevisan et al, 2001; Dignam et al, 2006; Reeves et al, 2007; Meyerhardt et al, 2008; Moon et al, 2008; Wolpin et al, 2009).”
BackgroundResultInfluentialWorldwide Variations in Colorectal Cancer
Center, M. M., Jemal, A., Smith, R. A., & Ward, E. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20038 · Cited by 1,276
Obesity and the role of adipose tissue in inflammation and metabolism
Greenberg, A. S., & Obin, M. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.461s · Cited by 1,273
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933 · cited 1×
“Angiopoietin-2 regulates vascular remodelling and endothelial responsiveness to pro-inflammatory cytokines (Fiedler et al, 2006).”
BackgroundObesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events
Moghaddam, A. A., Woodward, M., & Huxley, R. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0708 · Cited by 680 · cited 1×
“Epidemiological studies have shown that the risk for colorectal cancer development is strongly related to obesity and the metabolic syndrome (Moghaddam et al, 2007; Pais et al, 2009).”
BackgroundMetabolic syndrome, hyperinsulinemia, and colon cancer: a review
Giovannucci, E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 531
Sandhu, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.972 · Cited by 496
Effect of physical activity and body size on survival after diagnosis with colorectal cancer
Haydon, A. M. M. (2006) · Gut · doi:10.1136/gut.2005.068189 · Cited by 369
Coffelt, S. B., Tal, A. O., Scholz, A., De Palma, M., Patel, S., Urbich, C., Biswas, S. K., Murdoch, C., Plate, K. H., Reiss, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0012 · Cited by 343
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Dignam, J. J., Polite, B. N., Yothers, G., Raich, P., Colangelo, L., O'Connell, M. J., & Wolmark, N. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj442 · Cited by 325
Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2
Murdoch, C., Tazzyman, S., Webster, S., & Lewis, C. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7405 · Cited by 318 · cited 1×
“Mice with Ang-2 overexpressed in tumour vasculature had high serum Ang-2 levels, increased TEM infiltration of tumours and an increased number of tumour microvessels with immature phenotype (Murdoch et al, 2007; Coffelt et al, 2010).”
BackgroundMeyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Benson, A. B., Macdonald, J. S., & Fuchs, C. S. (2003) · Cancer · doi:10.1002/cncr.11544 · Cited by 306
Meyerhardt, J. A., Niedzwiecki, D., Hollis, D., Saltz, L. B., Mayer, R. J., Nelson, H., Whittom, R., Hantel, A., Thomas, J., & Fuchs, C. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6687 · Cited by 259
Cellular and molecular pathways linking inflammation and cancer
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena, P., Mantovani, A., & Sica, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.014 · Cited by 250
Cao, D., Hou, M., Guan, Y.-S., Jiang, M., Yang, Y., & Gou, H.-F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-432 · Cited by 244
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.
Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R. M., Bucana, C. D., & Ellis, L. M. (2001) · PubMed · Cited by 236
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231 · cited 2×
“…of obesity and metabolic syndrome as risk factors for colorectal cancer development, data are equivocal for their effects on colorectal cancer progression and outcome (Trevisan et al, 2001; Dignam et al, 2006; Reeves et al, 2007; Meyerhardt et al, 2008; Moon et al, 2008; Wolpin et al, 2009).”
BackgroundNozoe, T., Matsumata, T., Kitamura, M., & Sugimachi, K. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00204-9 · Cited by 223
Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
Tsujinaka, S., Konishi, F., Kawamura, Y. J., Saito, M., Tajima, N., Tanaka, O., & Lefor, A. T. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9395-0 · Cited by 213
Litton, J. K., Gonzalez-Angulo, A. M., Warneke, C. L., Buzdar, A. U., Kau, S.-W., Bondy, M., Mahabir, S., Hortobagyi, G. N., & Brewster, A. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4527 · Cited by 206
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., & Augustin, H. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1615 · Cited by 201
Markers of insulin resistance and colorectal cancer mortality.
Trevisan, M., Liu, J., Muti, P. C., Misciagna, G., Menotti, A., & Fucci, F. (2001) · PubMed · Cited by 189
Goede, V, Coutelle, O., Neuneier, J., Reinacher-Schick, A., Schnell, R., Koslowsky, T. C., Weihrauch, M. R., Cremer, B., Kashkar, H., Odenthal, M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605925 · Cited by 186
Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer
Moon, H.-G., Ju, Y.-T., Jeong, C.-Y., Jung, E.-J., Lee, Y.-J., Hong, S.-C., Ha, W.-S., Park, S.-T., & Choi, S.-K. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9891-4 · Cited by 184
Reinmuth, N., Fan, F., Liu, W., Parikh, A. A., Stoeltzing, O., Jung, Y. D., Bucana, C. D., Radinsky, R., Gallick, G. E., & Ellis, L. M. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000032411.41603.c2 · Cited by 174
Metabolic syndrome and risk of subsequent colorectal cancer
Pais, R., Silaghi, H., Silaghi, A. C., Rusu, M. L., & Dumitrascu, D. L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5141 · Cited by 174
GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy
Cantuaria, G., Fagotti, A., Ferrandina, G., Magalhaes, A., Nadji, M., Angioli, R., Penalver, M., Mancuso, S., & Scambia, G. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1144::aid-cncr1432>3.0.co;2-t · Cited by 166
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Komninou, D., Ayonote, A., Richie, J. P., & Rigas, B. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800410 · Cited by 156
Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer
Park, J. H., Park, K. J., Kim, Y. S., Sheen, S. S., Lee, K. S., Lee, H. N., Oh, Y. J., & Hwang, S. C. (2007) · CHEST Journal · doi:10.1378/chest.06-2915 · Cited by 117
Association between adiponectin, resistin, insulin resistance, and colorectal tumors
Gönüllü, G., Kahraman, H., Bedir, A., Bektaş, A., & Yücel, İ. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0828-6 · Cited by 111
Nguyen, X.-M. T., Lane, J., Smith, B. R., & Nguyen, N. T. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0904-9 · Cited by 109
Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Reinmuth, N., Bucana, C. D., & Ellis, L. M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1138::aid-cncr1431>3.0.co;2-l · Cited by 109
Tumour‐associated angiogenesis in human colorectal cancer
Rmali, K. A., Puntis, M. C. A., & Jiang, W. G. (2007) · Colorectal Disease · doi:10.1111/j.1463-1318.2006.01089.x · Cited by 92
Novel mechanism for obesity-induced colon cancer progression
Birmingham, J. M., Busik, J. V., Hansen-Smith, F. M., & Fenton, J. I. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp041 · Cited by 86
Turu, M. M., Slevin, M., Matou, S., West, D., Rodríguez, C., Luque, A., Grau-Olivares, M., Badimon, L., Martinez-Gonzalez, J., & Krupinski, J. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-47 · Cited by 75
Angiopoietin-2 in experimental colitis
Ganta, V. C., Cromer, W., Mills, G. L., Traylor, J., Jennings, M., Daley, S., Clark, B., Mathis, M. J., Bernas, M., Boktor, M., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21150 · Cited by 75
Variability in Reoperation Rates at 182 Hospitals: A Potential Target for Quality Improvement
Merkow, R. P., Bilimoria, K. Y., Cohen, M. E., Richards, K., Ko, C. Y., & Hall, B. L. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.07.003 · Cited by 63
Sarraf‐Yazdi, S., Mi, J., Moeller, B. J., Niu, X.-L., White, R. R., Kontos, C. D., Sullenger, B. A., Dewhirst, M. W., & Clary, B. M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.028 · Cited by 61
Fuchs, C. S., Goldberg, R. M., Sargent, D. J., Meyerhardt, J. A., Wolpin, B. M., Green, E. M., Pitot, H. C., & Pollak, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0480 · Cited by 60
Nozoe, T., Mori, E., Takahashi, I., & Ezaki, T. (2008) · Surgery Today · doi:10.1007/s00595-007-3680-8 · Cited by 53
Bello, G., Cailotto, F., Hanriot, D., Kolopp‐Sarda, M., Latger‐Cannard, V., Hess, K., Zannad, F. M., Longrois, D., & Ropars, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.046 · Cited by 47
Expression and prognostic significance of angiopoietin in colorectal carcinoma
Chung, Y., Hou, Y.-C., Chang, C.-N., & Hseu, T. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20423 · Cited by 42
Risk assessment in patients with drug-induced prolonged QT
Isbister, G. K., Kirkpatrick, C. M. J., & Duffull, S. B. (2007) · Cited by 32
Koukourakis, M. I., Kambouromiti, G. L., Pitsiava, D., Tsousou, P., Tsiarkatsi, M., & Kartalis, G. (2009) · Inflammation · doi:10.1007/s10753-009-9116-4 · Cited by 30
The Christchurch Tissue Bank to support cancer research.
Morrin, H. R., Gunningham, S. P., Currie, M. J., Dachs, G. U., Fox, S. B., & Robinson, B. A. (2005) · PubMed · Cited by 26
Self-citationYang, H., Nan, B., Yan, S., Li, M., Yao, Q. C., & Chen, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.014 · Cited by 15
Frizelle, F. (2009) · PubMed · Cited by 2
Research works printed but not linked: 1
- Ministry of Health (2007) Diabetes surveillance: population-based estimates and projections for New Zealand, 2001–2011: Public Health Intelligence Occasional Bulletin No. 46. Ministry of Health: Wellington. http://www.moh.govt.nz/moh.nsf/indexmh/diabetes-suveillance-population-estimates-projections-2001-2011, accessed 21 April 2010
Cited by
Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., & Lorton, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143080 · Cited by 274
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197
Microparticles in Angiogenesis: Therapeutic Potential
Martinez, M. C., & Andriantsitohaina, R. (2011) · Circulation Research · doi:10.1161/circresaha.110.233049 · Cited by 178
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Wei, X.-L., Wang, F.-H., Zhang, D.-S., Qiu, M.-Z., Ren, C., Jin, Y., Zhou, Y.-X., Wang, D.-S., He, M.-M., Bai, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1379-6 · Cited by 159
Metadata
- Authors
- Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J.
- Affiliations
- University of Otago (NZ)
- Christchurch Hospital (NZ)
- Corresponding author
- Currie, M J
- Venue
- British Journal of Cancer
- Published
- 2010-11-16
- Volume
- 104
- Issue
- 1
- Pages
- 51-59
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3039823
- OpenAlex
- W1987497125
- Cited by
- 78
- References
- 55
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 6
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tertiary Education Commission
- University of Otago
- Cancer Society of New Zealand
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- colorectal cancer, angiopoietin-2, C-reactive protein, obesity, insulin resistance, inflammation, angiogenesis, VEGF-A, insulin-like growth factor I, adiponectin, cancer survival, prognostic factors, tumor stage, obesity-associated inflammation
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, C-Peptide, C-Reactive Protein, Enzyme-Linked Immunosorbent Assay, Female, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Middle Aged, Obesity, Prospective Studies, Colorectal Neoplasms, Biomarkers, Body Mass Index, Survival Rate, Treatment Outcome, Vascular Endothelial Growth Factor A, Angiopoietin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.